A New and Specific Treatment for Idiopathic Membranous Nephropathy

A New and Specific Treatment for Idiopathic Membranous Nephropathy

Idiopathic

• Means that the reason for membranous nephropathy is unknown
• Possible reasons are cancer and diabetes
• Designation is made after secondary causes has been ruled out

Membranous nephropathy

• Means that the kidneys leak protein into the urine

• Most common in the ages of 30-50 for white males

• The acronym for the disorder is IMN
• Presence of protein in the kidney leads to a higher risk to develop failure
• It could be a result of

• Drugs NSAID, penicilamine
• Infections
• Parasitic diseases
• Hepatitis in kids

Cure is to remove the autoantibodies

The technology is a treatment that either treat the IMN or minimize the side effects of the current method

The current method is to inject high doses of steroid hormones

New method is autoantibody binding

Associations to be contacted are:

• American Society of Nephrology
• Renal Association, Renal Pathology Society
• Cardio Renal Society of America

Networks

• Specialized pharmacists in specialized renal clinic

• Houston VA
• Mayo Clinic
• Not Quest Diagnostics

Market size

• Patients will want to use it because it is usually detected in white man ages 30-40

• Who conversely could have renal failure at a young age meaning within 2 years

• Smaller compared to diabetes and cancer market MN market

• Pending to check the number of people affected with Associations

• IMN is found at the time of a routine examination

• 40% are detected
• 60% of the population likely with IMN is undetected for lack of symptoms like

• Burning sensation
• Smell
• By the time is detected is because they have renal failure

Price

The IMN patients would pay almost the same as those with renal failure and dialysis, cancer, and diabetes